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218a Monday, March 2, 2009single-molecule measurements and physiological forces. We believe that our
work provides first steps towards a theoretical framework to better understand
dynamic and cellular protein biomechanics and biological force generation.
We have been supported by a grant N202 0852 33 of the Ministry of Science
and Higher Education in Poland (to P.S.) and a fellowship of the European
Molecular Biology Organization (to H.J.).
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Single-molecule techniques provide a powerful means of exploring molecular
transitions such as the unfolding and refolding of a protein. However, the quan-
tification of bi-directional transitions and near-equilibrium phenomena poses
unique challenges, and is often limited by the detection resolution and long-
term stability of the instrument. We have developed unique optical tweezers
methods that address these problems, including an interference-based method
for high-resolution 3D bead tracking (~1 nm laterally, ~0.3 nm vertically,
at > 100 Hz), and a continuous autofocus system that stabilizes the trap height
to within 1-2 nm longterm [1-3]. We have used our instruments to quantify the
force-dependent unfolding and refolding kinetics of single protein domains
(e.g. spectrin [3,4]). These single-molecule studies are presented, together
with the accompanying probabilistic analysis that we have developed.
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It is known that even proteins, not involved into diseases, are able to form am-
yloid-like structures similar in final architecture of their fibrils. This fact sug-
gests that formation of aggregated cross-beta structure is a common property
of a polypeptide chain under appropriate conditions. Sperm whale apomyoglo-
bin was used to investigate amyloid formation because the properties and fold-
ing process of this protein are well known. Process of the apomyoglobin mutant
aggregation was monitored under conditions close to physiological ones (40C,
pH 5.5) by ThT binding, turbidity, FTIR spectroscopy and electron microscopy.
Mutated proteins contained a single point substitution at positions Val10 and
Met131 by Ala, Phe and Trp. It was shown that the WT apomyoglobin formed
aggregates not containing beta-structure, while variants of apomyoglobin have
shown significant increase of ThT fluorescence intensity and changes in a form of
FTIRspectra. These changes evidencedappearanceofbeta-structuredaggregates,
and EM images showed fibril-like aggregates. Kinetics of amyloid formation
monitored by turbidity and ThT binding allowed to calculate three rate constants
of amyloid formation and to distinguish three stages of this process. Obtained re-
sults suggest that the rate of the first stage is affected by a position of substitution,
and is not influenced by its type. In contrast, the rate of the second stage depends
on a type of substitution: it is slower for mutants with aromatic amino acid sub-
stitutions. This work was supported by INTAS grant 05-1000004-7747, partly
by the Howard Hughes Medical Institute Award 55005607 to A.V. Finkelstein
and by the RAS Program on ‘‘Molecular and Cellular Biology’’.
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Alpha-Synuclein and Amyloid-beta are amyloid forming proteins which aggre-
gate in Parkinson’s and Alzheimer’s disease brain, respectively. We designed
and synthesized a novel boronic acid- and chromene-based small moleculelibrary, and tested the molecules’ in vitro activity against alpha-Synuclein
and Amyloid-beta by examining the effect on the aggregation process. The ag-
gregation was monitored using the amyloid-specific Thioflavin T fluorescence,
as well as by native gel electrophoresis, and transmission electron microscopy.
We observed that some compounds were effective at stabilizing the initial
species, while others appear to stabilize a ring-like oligomeric intermediate
as observed by electron microscopy combined with single particle analysis.
Furthermore, some compounds were able to promote the formation of amyloid
fibers. Together, these results serve as a foundation for the future design of
small molecule inhibitors and diagnostic agents (PET-agents) for amyloid
fibers. In addition, they provide insights into the mechanism of aggregation
in many neurodegenerative diseases.
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Pressure tuning in combination with calorimetric, spectroscopic and structural
techniques (DSC, PPC, FTIR, SAXS, AFM) revealed new insights into the pre-
aggregated regime as well as mechanistic details about concurrent aggregation
pathways and the differential stability of insulin aggregates. A thorough ther-
modynamic approach has provided a coherent and precise description of
changes of the partial specific volume, heat capacity, the coefficient of thermal
expansion, as well as the adiabatic and isothermal compressibility of the protein
upon unfolding and aggregation. This was only possible due to a novel appli-
cation of ultrasound velocimetry and pressure perturbation calorimetry. Be-
sides pressure, also solvational perturbations, accomplished by the addition
of various salts and cosolvents such as glycerol, ethanol and TFE, have been
explored. They exert pronounced and diversified effects on the unfolding,
non-native assembly and fibril formation, which ultimately manifest in
morphological variations of mature aggregates and fibrils (strains). The phe-
nomenon of strains easily fits to a generalized protein energy landscape picture
involving an alternative comb-shaped aggregation funnel. The pressure vari-
able has also been explored to study more disease related amyloidogenic
proteins, such as PrP and IAPP. Several examples will be given.
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We present a novel microfluidic device for amyloid peptide aggregation re-
search. The device relies on the control of interfacial chemistry, which allows
miniaturizing of aggregation measurements to nanoliter volumes. In traditional
in vitro aggregation experiments, adsorption of amyloid peptides to various in-
terfaces has been shown to nucleate and to enhance peptide aggregation. The
problem of adsorption is even more pronounced upon miniaturization of aggre-
gation experiments. Miniaturization leads to an increase of the surface-to-vol-
ume ratio, and concomitantly to an increase of amyloid peptide aggregation if
the surface is not controlled. Nevertheless, miniaturization of aggregation ex-
periments is desirable for samples available only in small volumes, as for ex-
ample cerebrospinal fluid (CSF) from mice. CSF has recently gained interest
in Alzheimer research, however CSF analytics has been hampered to due the
small available volume.
In order tominiaturize and control the interfacial chemistry of aggregation exper-
iments we used a plug based microfluidic approach. Plugs are nanoliter sized
aqueous droplets formed in the flow of immiscible fluids inside microfluidic
channels. Upon peptide encapsulation into plugs, the unfavorable interfaces
are exchanged for an adjustable liquid/liquid interface. We show for one prom-
inent amyloid peptide, the Alzheimer’s peptide Ab(1-40), that aggregation in
plugs has kinetics of orders of magnitude slower than under standard conditions.
Further we show the applicability of this miniaturized system to aggregation ex-
periments by testing the inhibitory potency of CSF from wild type and ceAPPs-
wePS1DE9/TTR-/- mice on Ab aggregation. Using the plug-based approach, we
were able to perform over 750 experiments with a single mouse CSF sample of
5 ml in volume. The plug system offers many new opportunities to investigate
in vitro aggregation studies, as for example time controlled aging of amyloid pep-
tides, nucleation in a confined environment, and screening of drug components.
1129-Plat
Unraveling the Polyglutamine Aggregation Pathway in Huntington’s Dis-
ease by Small-Angle Neutron Scattering
Christopher B. Stanley1, Valerie Berthelier2.
1Oak Ridge National Laboratory, Oak Ridge, TN, USA, 2University of
Tennessee Medical Center, Knoxville, TN, USA.
